AU2001282118A1 - Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases - Google Patents
Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseasesInfo
- Publication number
- AU2001282118A1 AU2001282118A1 AU2001282118A AU8211801A AU2001282118A1 AU 2001282118 A1 AU2001282118 A1 AU 2001282118A1 AU 2001282118 A AU2001282118 A AU 2001282118A AU 8211801 A AU8211801 A AU 8211801A AU 2001282118 A1 AU2001282118 A1 AU 2001282118A1
- Authority
- AU
- Australia
- Prior art keywords
- airway diseases
- positively influence
- identifying substances
- chronic inflammatory
- inflammatory conditions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0021484 | 2000-09-01 | ||
GBGB0021484.1A GB0021484D0 (en) | 2000-09-01 | 2000-09-01 | Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
PCT/EP2001/009727 WO2002018938A1 (en) | 2000-09-01 | 2001-08-23 | Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001282118A1 true AU2001282118A1 (en) | 2002-03-13 |
Family
ID=9898663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001282118A Abandoned AU2001282118A1 (en) | 2000-09-01 | 2001-08-23 | Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1315963A1 (en) |
JP (1) | JP2004507262A (en) |
AU (1) | AU2001282118A1 (en) |
CA (1) | CA2418506C (en) |
GB (1) | GB0021484D0 (en) |
MX (1) | MXPA03001506A (en) |
WO (1) | WO2002018938A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1364017A2 (en) * | 2000-08-18 | 2003-11-26 | Novartis AG | Inflammation related g-protein coupled receptor |
WO2003023007A2 (en) | 2001-09-07 | 2003-03-20 | Bristol-Myers Squibb Company | Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy39 |
US6902902B2 (en) | 2001-11-27 | 2005-06-07 | Arena Pharmaceuticals, Inc. | Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders |
JP2005536187A (en) * | 2002-04-03 | 2005-12-02 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | Diagnosis and treatment of diseases associated with N-formyl peptide receptor-like 1 (FPRL1) |
US7189524B1 (en) | 2002-11-25 | 2007-03-13 | Amgen, Inc. | Receptor ligands and methods of modulating receptors |
WO2004071394A2 (en) * | 2003-02-13 | 2004-08-26 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with hm74 |
US7094572B2 (en) | 2003-03-14 | 2006-08-22 | Bristol-Myers Squibb | Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74 |
CN1921845A (en) * | 2004-02-20 | 2007-02-28 | 安万特药物公司 | Furosemide derivatives as modulators of HM74 and their use for the treatment of inflammation |
CA2556757C (en) * | 2004-02-20 | 2011-05-03 | Aventis Pharmaceuticals Inc. | Oxydecahydronaphthalene modulators of hm74 |
JP2009519017A (en) * | 2005-12-07 | 2009-05-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Treatment and diagnosis of inflammatory diseases |
JP6151129B2 (en) * | 2013-08-19 | 2017-06-21 | テルモ株式会社 | Fibrotic agent |
JP6210794B2 (en) * | 2013-08-19 | 2017-10-11 | テルモ株式会社 | Fibrotic agent |
CA3071193A1 (en) | 2017-07-26 | 2019-01-31 | Forty Seven, Inc. | Anti-sirp-alpha antibodies and related methods |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5648344A (en) * | 1990-07-30 | 1997-07-15 | Glycomed Incorporated | Methods of treating inflammation using selection binding compounds |
EP0592423B1 (en) * | 1990-08-06 | 2000-11-15 | Chiron Corporation | Methods for the identification of cytokine convertase inhibitors |
WO1994025570A1 (en) * | 1993-04-23 | 1994-11-10 | Sloan-Kettering Institute For Cancer Research | Method for screening for targets for anti-inflammatory or anti-allergic agents |
US6160088A (en) * | 1998-07-29 | 2000-12-12 | Sloan-Kettering Institute For Cancer | KDEL receptor inhibitors |
AU2030000A (en) * | 1998-11-25 | 2000-06-13 | Cadus Pharmaceutical Corporation | Methods and compositions for identifying receptor effectors |
US6379890B1 (en) * | 1998-12-11 | 2002-04-30 | Children's Hospital Medical Center | Method for determining asthma susceptibility |
EP1364017A2 (en) * | 2000-08-18 | 2003-11-26 | Novartis AG | Inflammation related g-protein coupled receptor |
-
2000
- 2000-09-01 GB GBGB0021484.1A patent/GB0021484D0/en not_active Ceased
-
2001
- 2001-08-23 EP EP01960700A patent/EP1315963A1/en not_active Withdrawn
- 2001-08-23 MX MXPA03001506A patent/MXPA03001506A/en active IP Right Grant
- 2001-08-23 AU AU2001282118A patent/AU2001282118A1/en not_active Abandoned
- 2001-08-23 CA CA002418506A patent/CA2418506C/en not_active Expired - Fee Related
- 2001-08-23 JP JP2002523607A patent/JP2004507262A/en active Pending
- 2001-08-23 WO PCT/EP2001/009727 patent/WO2002018938A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CA2418506A1 (en) | 2002-03-07 |
MXPA03001506A (en) | 2003-06-09 |
GB0021484D0 (en) | 2000-10-18 |
CA2418506C (en) | 2009-04-28 |
JP2004507262A (en) | 2004-03-11 |
WO2002018938A1 (en) | 2002-03-07 |
EP1315963A1 (en) | 2003-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003250829A1 (en) | System and method for the automatic detection of the expiratory flow limitation | |
AU2002316137A1 (en) | Method of determining protein interaction inhibitors | |
AU2001234608A1 (en) | Methods for analysis of gene expression | |
AU7861800A (en) | Method for determining total cost of ownership | |
AU2001282118A1 (en) | Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases | |
AU2002312859A1 (en) | Method for determining gene expression | |
AU2002216080A1 (en) | Method for determining competing risks | |
AU2000256675A1 (en) | Inspection system for edges of glass | |
AU2001257903A1 (en) | Method for treatment of neurodegenerative diseases | |
AU2002326949A1 (en) | Method for the inhibition of methanogenesis | |
AU2001271841A1 (en) | Methods for identifying combinations of drugs | |
AU2003220034A1 (en) | An early detection marker for chronic inflammatory associated diseases | |
AU2002238274A1 (en) | Method for the detection of nucleic acid molecules | |
AU2001287268A1 (en) | Method of identifying inhibitors of tie-2 | |
AU2002301109A1 (en) | Method for the prediction of preeclampsia and other diseases | |
AU2002221950A1 (en) | Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases | |
AU2002240840A1 (en) | Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases | |
AU2001227708A1 (en) | Methods for identifying inhibitors of neuronal degeneration | |
AU2003223041A1 (en) | Method for analysis of methylated nucleic acids | |
AU6346901A (en) | Method of detecting inflammatory lung disorders | |
AU2001265050A1 (en) | Practical screening method for detecting genetic disorders of sterol metabolism | |
WO2002052269A3 (en) | Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases | |
GB0029539D0 (en) | Method for identifying modulatorss of transcription | |
AU2001260463A1 (en) | Method for analysis of metabolic pathways | |
AU2001253092A1 (en) | Method for detection of truncated proteins |